Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,562 | 10,623 | 14,876 | 14,581 | 17,535 |
| Receivables | 105,817 | 98,902 | 100,602 | 92,187 | 88,030 |
| Inventories | 34,386 | 33,952 | 36,400 | 38,004 | 39,364 |
| Income taxes - deferred | 10,575 | 10,596 | 11,992 | 9,596 | 9,691 |
| TOTAL | $177,213 | $169,076 | $175,673 | $168,195 | $168,000 |
| Non-Current Assets | |||||
| PPE Net | 96,298 | 95,194 | 95,900 | 96,132 | 97,620 |
| Intangibles | 149,631 | 142,254 | 142,359 | 0 | 0 |
| Other Non-Current Assets | 8,605 | 7,335 | 7,669 | 150,269 | 143,737 |
| TOTAL | $254,534 | $244,783 | $245,928 | $246,401 | $241,357 |
| Total Assets | $431,747 | $413,859 | $421,601 | $414,596 | $409,357 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,525 | 1,185 | 1,145 | 823 | 30 |
| Accounts payable and accrued liabilities | 23,063 | 25,153 | 25,407 | 15,563 | 15,339 |
| Accrued Expenses | 12,144 | 11,486 | 12,553 | N/A | N/A |
| TOTAL | $55,210 | $46,851 | $50,084 | $32,604 | $32,060 |
| Non-Current Liabilities | |||||
| Long Term Debt | 100,368 | 92,022 | 88,035 | 88,000 | 89,000 |
| Deferred Revenues | N/A | 2,561 | 1,709 | N/A | N/A |
| Other Non-Current Liabilities | 11,718 | 10,563 | 10,875 | 22,551 | 22,195 |
| TOTAL | $126,051 | $116,557 | $113,371 | $110,551 | $111,195 |
| Total Liabilities | $181,261 | $163,408 | $163,455 | $143,155 | $143,255 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,191 | 63,257 | 63,252 | 66,548 | 66,530 |
| Common Shares | 547 | 546 | 546 | 546 | 546 |
| Retained earnings | 85,039 | 80,404 | 79,247 | 83,546 | 78,252 |
| Other shareholders' equity | 406 | 136 | -11 | 0 | 0 |
| TOTAL | $250,486 | $250,451 | $258,146 | $271,441 | $266,102 |
| Total Liabilities And Equity | $431,747 | $413,859 | $421,601 | $414,596 | $409,357 |